Meeting Abstracts & Presentations
Plebanek, M., Rezazade Bazaz, M., Nguyen, Y., Wang, M., Theivanthiran, B., Hanks, B.A. mregDCs Propagate Tumor Immune Tolerance by Suppressing Conventional DC-dependent Activation of CD8+ T Cells via Paracrine PCSK9 Signaling. 2025 SITC Annual Meeting. Washington, DC.
Wang, M., Plebanek, M., Rezazade Bazaz, M., Theivanthiran, B., Hanks, B.A. Tumor Extracellular Vesicles Trigger a Dendritic Cell Stress Response to Promote Immune Evasion and Immunotherapy Resistance. 2025 AACR Annual Meeting. Chicago, IL.
Discovery of Tumor Immune Evasion Mechanisms and Their Translation into the Clinic. UNC MD/PhD Program Seminar. September 8, 2025. University of North Carolina. Chapel Hill, NC.
Discovery and Translation of Tumor Immune Evasion Mechanisms. Bladder Cancer Research Group. April 23, 2025. Lineberger Comprehensive Cancer Center. University of North Carolina. Chapel Hill, NC.
Plebanek, M., Rezazadebazaz, M., Nguen, Y., Howell, K., Wang, M., Theivanthiran, B., DeVito, N., Hanks, B.A. Role of NR4A1 in mregDC Pro-tolerogenic Function and Immunotherapy Response. 2024 SITC Annual Meeting. Houston, TX.
Theivanthiran, B., Nguyen, Y., Howell, K., Chakraborty, S., Plebanek, M., DeVito, N.C., Hanks, B.A. Tumor NLRP3 Amplification Suppresses NLRC5 Expression and MHC Class I Antigen Processing and Presentation while Driving Anti-PD-1 Immunotherapy Resistance. 2024 SITC Annual Meeting. Houston, TX.
The Critical Role of Translational Research in the Future of Immuno-Oncology: A Case Study. Keynote Presentation. 2024 Annual Immuno-Oncology Retreat. October 25, 2024. Atrium Health Wake Forest Baptist Comprehensive Cancer Center. Winston Salem, NC.
The Role of the NLRP3-HSP70 Signaling Axis in Gastric Cancer Immunotherapy Resistance. 2024 AACR Grantee Summit: Igniting Innovation in Cancer Research. October 8, 2024. Philadelphia, PA.
Role of Inflammation and Stress in Melanoma Immune Evasion, Relapse, and Immunotherapy Resistance. Pinnell Center for Investigative Dermatology Annual Research Symposium. Duke University. Durham, NC. September 6, 2024.
Tumor-mediated Education of Bone Marrow Neutrophil Progenitors Facilitates the Development of Checkpoint Inhibitor-associated Toxicity. DCI Immuno-Oncology Seminar. Durham, NC. August 20, 2024
Exploring the Role of Dendritic Cell Tolerization and the NLRP3 Inflammasome in Cancer Immunotherapy Resistance. University of North Carolina Lineberger Comprehensive Cancer Center. Chapel Hill, NC May 29, 2024
Tumor-mediated Education of Bone Marrow Neutrophil Progenitors Facilitates the Development of Checkpoint Inhibitor-associated Toxicity. 3rd International Symposium of Clinical Immunology. Hokkaido, Japan. May 16, 2024
Role of the Tumor-intrinsic NLRP3-HSP70 Signaling Axis in Immune Evasion and Immunotherapy Resistance. Duke Radiation Oncology Program Retreat. Durham, NC May 7, 2024.
Discovery of a Lactate-SREBP2 Signaling Axis in Tumor-mediated Dendritic Cell Tolerization and Immune Evasion. DCI Scholar Research Symposium. Durham, NC. March 25, 2024